Synergistic Effects of Transplanted Endothelial Progenitor Cells and RWJ 67657 in Diabetic Ischemic Stroke Models

Stroke

Volumn 46, Issue 7, 2015, Pages 1938-1946

  Bai, Ying Ying ^a   Wang, Lishan ^b   Chang, Di ^a   Zhao, Zhen ^a   Lu, Chun Qiang ^a   Wang, Guozheng ^c   Ju, Shenghong ^a  

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

cell transplantation; diabetes mellitus; endothelial progenitor cells; inflammation; p38 mitogen activated protein kinases

Indexed keywords

4 [4 (4 FLUOROPHENYL) 1 (3 PHENYLPROPYL) 5 (4 PYRIDINYL) 1H IMIDAZOL 2 YL] 3 BUTYN 1 OL; BETA GALACTOSIDASE; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOSE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; PYRIDINE DERIVATIVE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DEGENERATION; DIABETES MELLITUS; DIFFUSION TENSOR IMAGING; DRUG POTENTIATION; ENDOTHELIAL PROGENITOR CELL; ENZYME PHOSPHORYLATION; FRACTIONAL ANISOTROPY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBVENTRICULAR ZONE; WESTERN BLOTTING; WHITE MATTER; ANIMAL; ANTAGONISTS AND INHIBITORS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODEL; PATHOLOGY; PROCEDURES; STROKE; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; BRAIN ISCHEMIA; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENDOTHELIAL PROGENITOR CELLS; IMIDAZOLES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; STEM CELL TRANSPLANTATION; STROKE; TREATMENT OUTCOME;

EID: 84941068004     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.008495     Document Type: Article

References (35)

1. Navaratna D, Guo SZ, Hayakawa K, Wang X, Gerhardinger C, Lo EH. Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes. 2011;60:1789-1796. doi: 10.2337/db10-1371.
2. Kaarisalo MM, Raïhä I, Sivenius J, Immonen-Raïhä P, Lehtonen A, Sarti C, et al. Diabetes worsens the outcome of acute ischemic stroke. Diabetes Res Clin Pract. 2005;69:293-298. doi: 10.1016/j.diabres.2005.02.001.
3. Zhu M, Bi X, Jia Q, Shangguan S. The possible mechanism for impaired angiogenesis after transient focal ischemia in type 2 diabetic GK rats: different expressions of angiostatin and vascular endothelial growth factor. Biomed Pharmacother. 2010;64:208-213. doi: 10.1016/j. biopha.2009.08.005.
4. Stem Cell Therapies as an Emerging Paradigm in Stroke Participants. Stem cell therapies as an emerging paradigm in stroke (steps): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke. 2009;40:510-515.
5. Fan Y, Shen F, Frenzel T, Zhu W, Ye J, Liu J, et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol. 2010;67:488-497. doi: 10.1002/ana.21919.
6. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004;114:330-338. doi: 10.1172/JCI20622.
7. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106:2781-2786.
8. Bai YY, Gao X, Wang YC, Peng XG, Chang D, Zheng S, et al. Imageguided pro-angiogenic therapy in diabetic stroke mouse models using a multi-modal nanoprobe. Theranostics. 2014;4:787-797. doi: 10.7150/thno.9525.
9. Chang J, Li Y, Huang Y, Lam KS, Hoo RL, Wong WT, et al. Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes. 2010;59:2949-2959. doi:10.2337/db10-0582.
10. Wadsworth SA, Cavender DE, Beers SA, Lalan P, Schafer PH, Malloy EA, et al. RWJ 67657, a potent, orally active inhibitor of p38 mitogenactivated protein kinase. J Pharmacol Exp Ther. 1999;291:680-687.
11. Bai YY, Wang L, Peng XG, Wang YC, Chang D, Zheng S, et al. Noninvasive monitoring of transplanted endothelial progenitor cells in diabetic ischemic stroke models. Biomaterials. 2015;40:43-50. doi:10.1016/j.biomaterials.2014.11.018.
12. Westra J, Limburg PC, de Boer P, van Rijswijk MH. Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts. Ann Rheum Dis. 2004;63:1453-1459. doi: 10.1136/ard.2003.013011.
13. See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, et al. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol. 2004;44:1679-1689. doi: 10.1016/j. jacc.2004.07.038.
14. Saiki R, Nishimura K, Ishii I, Omura T, Okuyama S, Kashiwagi K, et al. Intense correlation between brain infarction and proteinconjugated acrolein. Stroke. 2009;40:3356-3361. doi: 10.1161/STROKEAHA.109.553248.
15. Cui X, Chopp M, Zacharek A, Cui Y, Roberts C, Chen J. The neurorestorative benefit of GW3965 treatment of stroke in mice. Stroke. 2013;44:153-161. doi: 10.1161/STROKEAHA.112.677682.
16. Chen J, Zacharek A, Zhang C, Jiang H, Li Y, Roberts C, et al. Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci. 2005;25:2366-2375. doi: 10.1523/JNEUROSCI.5071-04.2005.
17. Cui X, Chopp M, Zacharek A, Ye X, Roberts C, Chen J. Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke. Neurobiol Dis. 2011;43:285-292. doi: 10.1016/j. nbd.2011.04.005.
18. Medina RJ, O'Neill CL, Humphreys MW, Gardiner TA, Stitt AW. Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy. Invest Ophthalmol Vis Sci. 2010;51:5906-5913. doi: 10.1167/iovs.09-4951.
19. Chen J, Chen S, Chen Y, Zhang C, Wang J, Zhang W, et al. Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage. Am J Physiol Endocrinol Metab. 2011;301:E62-E71. doi: 10.1152/ajpendo.00026.2011.
20. Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation. 2005;111:1184-1191. doi: 10.1161/01. CIR.0000157156.85397.A1.
21. He XY, Chen ZZ, Cai YQ, Xu G, Shang JH, Kou SB, et al. Expression of cytokines in rat brain with focal cerebral ischemia after grafting with bone marrow stromal cells and endothelial progenitor cells. Cytotherapy. 2011;13:46-53. doi: 10.3109/14653249.2010.510505.
22. Moisan A, Favre IM, Rome C, Grillon E, Naegele B, Barbieux M, et al. Microvascular plasticity after experimental stroke: a molecular and MRI study. Cerebrovasc Dis. 2014;38:344-353. doi: 10.1159/000368597.
23. Nakao S. Impact of anti-VEGF therapy on the cellular microenvironment in retinal angiogenesis. Nihon Ganka Gakkai Zasshi. 2014;118:943-952.
24. Cui X, Chopp M, Shehadah A, Zacharek A, Kuzmin-Nichols N, Sanberg CD, et al. Therapeutic benefit of treatment of stroke with simvastatin and human umbilical cord blood cells: neurogenesis, synaptic plasticity, and axon growth. Cell Transplant. 2012;21:845-856. doi:10.3727/096368911X627417.
25. Piao CS, Kim JB, Han PL, Lee JK. Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult. J Neurosci Res. 2003;73:537-544. doi: 10.1002/jnr.10671.
26. Legos JJ, Erhardt JA, White RF, Lenhard SC, Chandra S, Parsons AA, et al. SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Res. 2001;892:70-77.
27. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, et al. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther. 2001;296:312-321.
28. Grome JJ, Gojowczyk G, Hofmann W, Graham DI. Quantitation of photochemically induced focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1988;8:89-95. doi: 10.1038/jcbfm.1988.11.
29. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature. 2010;468:305-309. doi: 10.1038/nature09511.
30. Lee JK, Kim JE, Sivula M, Strittmatter SM. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci. 2004;24:6209-6217. doi: 10.1523/JNEUROSCI.1643-04.2004.
31. Borich MR, Wadden KP, Boyd LA. Establishing the reproducibility of two approaches to quantify white matter tract integrity in stroke. Neuroimage. 2012;59:2393-2400. doi: 10.1016/j.neuroimage.2011.09.009.
32. Ding G, Jiang Q, Li L, Zhang L, Zhang ZG, Ledbetter KA, et al. Magnetic resonance imaging investigation of axonal remodeling and angiogenesis after embolic stroke in sildenafil-treated rats. J Cereb Blood Flow Metab. 2008;28:1440-1448. doi: 10.1038/jcbfm.2008.33.
33. van Velthoven CT, van de Looij Y, Kavelaars A, Zijlstra J, van Bel F, Huppi PS, et al. Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice. Ann Neurol. 2012;71:785-796. doi: 10.1002/ana.23543.
34. Sotak CH. The role of diffusion tensor imaging in the evaluation of ischemic brain injury-a review. NMR Biomed. 2002;15:561-569. doi:10.1002/nbm.786.
35. Shereen A, Nemkul N, Yang D, Adhami F, Dunn RS, Hazen ML, et al. Ex vivo diffusion tensor imaging and neuropathological correlation in a murine model of hypoxia-ischemia-induced thrombotic stroke. J Cereb Blood Flow Metab. 2011;31:1155-1169. doi: 10.1038/jcbfm.2010.212.